Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
15.01. | Auna (NYSE:AUNA) Stock Price Down 3.2% - Time to Sell? | 4 | MarketBeat | ||
AUNA Aktie jetzt für 0€ handeln | |||||
10.01. | Auna (NYSE:AUNA) Sees Large Volume Increase - Here's Why | 3 | MarketBeat | ||
31.12.24 | AUNA S.A. - 6-K, Report of foreign issuer | - | SEC Filings | ||
19.12.24 | AUNA S.A. - 6-K, Report of foreign issuer | - | SEC Filings | ||
02.12.24 | AUNA S.A. - 6-K, Report of foreign issuer | - | SEC Filings | ||
19.11.24 | Auna S.A.: Auna Announces 3Q24 Financial Results | 85 | Business Wire | Adjusted EBITDA increases 23% YoY FXN, maintaining strong growth Leverage ratio decreases 0.4x to 3.7x Auna (NYSE: AUNA) ("Auna" or the "Company"), a leading healthcare platform in Latin America... ► Artikel lesen | |
19.11.24 | Auna Announces 3Q24 Financial Results | 155 | Business Wire | LUXEMBOURG--(BUSINESS WIRE)--Auna (NYSE: AUNA) ("Auna" or the "Company"), a leading healthcare platform in Latin America with operations in Mexico, Peru and Colombia, today announced unaudited... ► Artikel lesen | |
19.11.24 | AUNA S.A. - 6-K, Report of foreign issuer | - | SEC Filings | ||
30.10.24 | Auna S.A.: Auna Announces Reporting Dates for Third Quarter 2024 Financial Results | 246 | Business Wire | Auna S.A. (NYSE: AUNA) ("Auna" or "the Company"), a leading Latin American healthcare services and plan provider with operations in Mexico, Peru and Colombia, announced today the reporting dates... ► Artikel lesen | |
03.09.24 | AUNA S.A. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
21.08.24 | Auna reports Q2 results | 2 | Seeking Alpha | ||
21.08.24 | AUNA S.A. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
21.08.24 | Auna S.A.: Auna Announces 2Q24 Financial Results | 680 | Business Wire | Adjusted EBITDA increases 31% YoY, consolidating strong results OncoMexico launched in Monterrey Auna (NYSE: AUNA) ("Auna" or the "Company"), a leading healthcare platform in Latin America... ► Artikel lesen | |
21.08.24 | Auna Announces 2Q24 Financial Results | 152 | Business Wire | LUXEMBOURG--(BUSINESS WIRE)--Auna (NYSE: AUNA) ("Auna" or the "Company"), a leading healthcare platform in Latin America with operations in Mexico, Colombia and Peru, today announced unaudited... ► Artikel lesen | |
09.08.24 | AUNA S.A. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
30.07.24 | Auna S.A.: Auna Announces Reporting Dates for Second Quarter 2024 Financial Results | 301 | Business Wire | Auna S.A. (NYSE: AUNA) ("Auna" or "the Company"), a leading Latin American healthcare services and plan provider with operations in Mexico, Peru and Colombia, announced today the reporting dates... ► Artikel lesen | |
22.05.24 | Auna S.A.: Auna Announces 1Q24 Financial Results | 425 | Business Wire | Revenue increases 20% YoY to S/1,076 million, with operating profit increasing 26% to S/182 million Adjusted EBITDA margin of 20.4% in Peruvian operations Auna (NYSE: AUNA) ("Auna" or the "Company")... ► Artikel lesen | |
03.04.24 | XFRA NEW INSTRUMENTS AVAILABLE ON XETRA - 03.04.2024 | 605 | Xetra Newsboard | The following instruments on XETRA do have their first trading 03.04.2024 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 03.04.2024
Aktien
1 LU2791994721 Auna S.A.
2 US86959X1072... ► Artikel lesen | |
22.03.24 | Auna Debuts International Stock Market With $360 Mln IPO Proceeds | 809 | AFX News | WASHINGTON (dpa-AFX) - Healthcare company, Auna S.A. (AUNA), Friday announced that it has raised $360 million in proceeds through Initial Public Offering or IPO trading on the New York Stock... ► Artikel lesen | |
22.03.24 | Auna S.A.: Auna Raises US$360 Million in Gross Proceeds via NYSE IPO, Marking Its Debut in the International Equity Markets | 775 | Business Wire | Auna's mission is to transform healthcare in Latin America, providing access to a highly integrated offering of quality healthcare services in Spanish-speaking Americas.
Auna has built... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
BRIGHTSPRING HEALTH SERVICES | 20,890 | 0,00 % | BrightSpring Health Services, Inc. Enters into Definitive Agreement to Divest Community Living Business to Sevita; Reports Preliminary 2024 Financial Results and Provides 2025 Guidance Excluding Community Living | Streamlined organization and Provider Services segment to optimize resource allocationProvider Services focus on Home Health/Hospice, Personal Care, Rehabilitation Services, and Care Management strategic... ► Artikel lesen | |
ATRICURE | 39,630 | 0,00 % | AtriCure (NASDAQ:ATRC) Hits New 52-Week High - Should You Buy? | ||
PROCEPT BIOROBOTICS | 69,72 | 0,00 % | PROCEPT BioRobotics (NASDAQ:PRCT) Trading Down 2.8% - Should You Sell? | ||
GERRESHEIMER | 66,90 | -0,22 % | EQS-PVR: Gerresheimer AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution | EQS Voting Rights Announcement: Gerresheimer AG
Gerresheimer AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of... ► Artikel lesen | |
SIEMENS HEALTHINEERS | 54,14 | +0,67 % | Siemens Healthineers-Aktie: Kurs klettert leicht (53,42 €) | Am deutschen Aktienmarkt liegt das Wertpapier von Siemens Healthineers aktuell im Plus. Die Aktie kostete zuletzt 53,42 Euro. Die Aktie von Siemens Healthineers verzeichnet gegenwärtig einen Wertanstieg... ► Artikel lesen | |
FRESENIUS | 36,140 | -0,19 % | DAX-Check LIVE: Fresenius, Hypoport, Kontron, Lanxess, Nemetschek, Nordex, Porsche AG, RWE, SAP & Co | Der DAX hat gestern die nächste Tausendermarke übersprungen. Erstmalig überwand er 21.000 Punkte. Am Ende des Tages ging er knapp darunter aus dem Handel. Das Tagesplus betrug 0,42 Prozent. Worauf es... ► Artikel lesen | |
CARL ZEISS MEDITEC | 48,840 | +0,08 % | JPMORGAN stuft CARL ZEISS MEDITEC AG auf 'Underweight' | NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat die Einstufung für Carl Zeiss Meditec mit einem Kursziel von 40 Euro auf "Underweight" belassen. Das erste Geschäftsquartal dürfte mau ausfallen... ► Artikel lesen | |
GENEDX | 74,33 | 0,00 % | GeneDx Announces Preliminary 2024 Financial Results | STAMFORD, Conn.--(BUSINESS WIRE)--GeneDx Holdings Corp. (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today reported preliminary financial results for... ► Artikel lesen | |
RXSIGHT | 30,920 | 0,00 % | RxSight, Inc. Announces Preliminary Unaudited Fourth Quarter and Full-Year 2024 Financial and Operational Results and 2025 Guidance | ALISO VIEJO, Calif., Jan. 12, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) - RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following... ► Artikel lesen | |
PROGYNY | 21,470 | 0,00 % | Progyny beruft Gesundheitsexpertin Debra Morris in den Vorstand | ||
ALIGNMENT HEALTHCARE | 14,555 | 0,00 % | Alignment Healthcare is latest to sue Medicare over Star Ratings | ||
FRESENIUS MEDICAL CARE | 44,310 | -0,07 % | GOLDMAN SACHS stuft FMC FRESENIUS MEDICAL CARE AG & CO KGAA auf 'Buy' | NEW YORK (dpa-AFX Analyser) - Die US-Investmentbank Goldman Sachs hat die Einstufung für FMC mit einem Kursziel von 52 Euro auf "Buy" belassen. Analyst Richard Felton nahm in einer am Montagabend vorliegenden... ► Artikel lesen | |
NANO-X IMAGING | 8,365 | 0,00 % | Nano-X Imaging LTD.: Nanox.ARC Imaging System Receives FDA Clearance for General Use, Including Pulmonary Indication | Nanox.ARC receives additional FDA clearance to produce tomographic images for general use, including pulmonary, intra-abdominal and paranasal indications, in addition to its previously cleared indication... ► Artikel lesen | |
TREACE MEDICAL CONCEPTS | 9,270 | 0,00 % | Treace Medical Concepts, Inc.: Treace Appoints Guy Guglielmino as Chief Commercial Officer | PONTE VEDRA, Fla., Dec. 02, 2024 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. ("Treace" or the "Company") (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical... ► Artikel lesen | |
HELIUS MEDICAL | 1,010 | 0,00 % | Helius Medical Technologies, Inc. Announces Strong Enrollment of its Stroke Pivotal Study Exceeding Initial Target | --128 enrolled participants, as of December 31, 2024, exceeds initial target of 90 participants-- --150 maximum participant enrollment projected by end of January-- --The stroke registrational program... ► Artikel lesen |